Chelsea Counsel Company’s Elevance Health ELV Stock Holding History

Chelsea Counsel Company’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,000	Closed	-$280K	–	141
2015 Q3	$280K	Hold	2,000	–	–	0.07%	130
2015 Q2	$328K	Buy	2,000 +600	+43%	+$95.9K	0.07%	126
2015 Q1	$216K	Buy	+1,400	New	+$199K	0.05%	127
2014 Q4	–	Sell	-2,000	Closed	-$239K	–	139
2014 Q3	$239K	Hold	2,000	–	–	0.05%	119
2014 Q2	$215K	Buy	+2,000	New	+$206K	0.04%	119

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Chelsea Counsel Company's ELV Position: Q4 2015 in Review

Chelsea Counsel Company sold out of Elevance Health (ELV) in Q4 2015, closing a stake of 2,000 shares — an estimated $280K sold.

Chelsea Counsel Company first reported a position in ELV in Q2 2014 and held it in 5 quarters. The position peaked at $328K in Q2 2015. 765 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

Chelsea Counsel Company reported no remaining Elevance Health position as of Q4 2015 after selling out during the quarter.
Chelsea Counsel Company sold 2,000 Elevance Health shares in Q4 2015, an estimated $280K.
Chelsea Counsel Company first reported a position in Elevance Health in Q2 2014 and held it in 5 quarters.
Chelsea Counsel Company's Elevance Health position peaked at $328K in Q2 2015.
765 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Chelsea Counsel Company's 13F filing for Q4 2015, filed 7 Apr 2016.